CNBX Pharmaceuticals Inc. (CNBX)

CNBX Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	0.01	0.03	0.13	0.12	1.39	0.78
Cash & Short-Term Investments	0.01	0.03	0.13	0.12	1.39	0.78
Cash Growth	-81.41%	-79.63%	10.37%	-91.52%	78.30%	-77.92%
Prepaid Expenses	0	0	0.09	0.08	0.2	0.15
Total Current Assets	0.02	0.03	0.22	0.2	1.59	0.93
Property, Plant & Equipment	-	-	0.27	0.44	0.64	0.86
Long-Term Investments	-	-	-	0.18	0.85	0.43
Total Assets	0.02	0.03	0.5	0.81	3.08	2.22
Accounts Payable	0.04	0.04	0.34	0.46	0.18	0.23
Accrued Expenses	-	0.93	0.61	-	-	-
Short-Term Debt	1.34	1.3	1.34	1.76	0.87	-
Other Current Liabilities	1.17	0.24	0.22	0.22	0.22	0.22
Total Current Liabilities	2.56	2.51	2.52	2.44	1.27	0.45
Other Long-Term Liabilities	-	-	-	0	-	-
Total Liabilities	2.56	2.51	2.52	2.44	1.27	0.45
Common Stock	0.01	0	0	0	0.01	0.01
Additional Paid-In Capital	22.57	22.47	22.24	18.03	17.06	15.37
Retained Earnings	-25.12	-24.95	-24.26	-20.55	-16.83	-13.63
Comprehensive Income & Other	-	-	-	0.88	1.55	0.01
Shareholders' Equity	-2.54	-2.48	-2.02	-1.63	1.81	1.76
Total Liabilities & Equity	0.02	0.03	0.5	0.81	3.08	2.22
Total Debt	1.34	1.3	1.34	1.76	0.87	-
Net Cash (Debt)	-1.33	-1.27	-1.21	-1.64	0.51	0.78
Net Cash Growth	-	-	-	-	-33.83%	-77.92%
Net Cash Per Share	-0.04	-0.04	-0.14	-1.34	0.45	0.69
Filing Date Shares Outstanding	92.51	31.11	28.31	1.26	1.24	1.13
Total Common Shares Outstanding	92.51	31.11	22.61	1.26	1.24	1.13
Working Capital	-2.54	-2.48	-2.29	-2.25	0.32	0.48
Book Value Per Share	-0.03	-0.08	-0.09	-1.30	1.46	1.57
Tangible Book Value	-2.54	-2.48	-2.02	-1.63	1.81	1.76
Tangible Book Value Per Share	-0.03	-0.08	-0.09	-1.30	1.46	1.57

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.